These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31746987)

  • 1. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
    Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
    Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the tumor volume doubling time in clinical T1 non-small cell lung cancer with solid radiological findings.
    Nakahashi K; Shiono S; Nakatsuka M; Endo M
    J Surg Oncol; 2022 Dec; 126(7):1330-1340. PubMed ID: 35921201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
    Liu M; Mu J; Song F; Liu X; Jing W; Lv F
    Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
    Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
    Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.
    Li Z; Pan C; Xu W; Zhao C; Pan X; Wang Z; Wu W; Chen L
    Respir Res; 2024 Feb; 25(1):96. PubMed ID: 38383329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non-Small Cell Lung Cancer.
    Takenaka T; Yamazaki K; Miura N; Mori R; Takeo S
    J Thorac Oncol; 2016 Jul; 11(7):1074-80. PubMed ID: 26899756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1245-1253. PubMed ID: 32893296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.
    Park S; Lee SM; Kim S; Lee JG; Choi S; Do KH; Seo JB
    Radiology; 2020 Jun; 295(3):703-712. PubMed ID: 32228296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.
    Domachevsky L; Groshar D; Galili R; Saute M; Bernstine H
    Eur Radiol; 2015 Nov; 25(11):3361-7. PubMed ID: 25929940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.
    Okamoto T; Miyawaki M; Toyokawa G; Karashima T; Abe M; Takumi Y; Hashimoto T; Osoegawa A; Tagawa T; Takeuchi H; Shimokawa M; Sugio K
    Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):219-226. PubMed ID: 34561707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progression of non-small cell lung cancer from diagnosis to surgery.
    McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.
    Huang CS; Chien HC; Chen CK; Yeh YC; Hsu PK; Chen HS; Hsieh CC; Hsu HS; Huang BS; Shih CC
    Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):537-545. PubMed ID: 33332546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
    Ohtaki Y; Shimizu K; Kaira K; Nagashima T; Obayashi K; Nakazawa S; Kakegawa S; Igai H; Kamiyoshihara M; Nishiyama M; Takeyoshi I
    Surg Today; 2016 Oct; 46(10):1196-208. PubMed ID: 26782692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.